Table 3.
Cost and effects in a situation with and without the addition of PO to PE screening for different assumptions of the model parameters, per 100,000 infants (2017 €)
| Sensitivity analysis | Situation with PO screening | Situation without PO screening | Cost-effectiveness ratio Costs per additional timely detected infant with CCHD |
||
|---|---|---|---|---|---|
| Costs | Effects | Costs | Effects | ||
| Only PO measurement at day 1 | 1,299,000 | 19 | 252,000 | 11 | 128,000 |
| Higher sensitivity PO (70%) | 1,677,000 | 30 | 252,000 | 11 | 86,000 |
| Shorter depreciation period pulse oximeter (5 years) | 2,025,000 | 23 | 252,000 | 11 | 148,000 |
| Lower costs cardiac ultrasound (€250) | 1,627,000 | 23 | 252,000 | 11 | 136,000 |
| Base case | 1,922,000 | 23 | 252,000 | 11 | 139,000 |